Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Eun | - |
dc.contributor.author | An, Ying | - |
dc.contributor.author | Kwon, Junhee | - |
dc.contributor.author | Kim, Keun Il | - |
dc.contributor.author | Jeon, Raok | - |
dc.date.available | 2021-02-22T11:12:54Z | - |
dc.date.issued | 2017-07 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.issn | 1464-3391 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/8251 | - |
dc.description.abstract | A strong relationship between abnormal functions of Aurora kinases and tumorigenesis has been reported for decades. Consequently, Aurora kinases serve as potential targets for anticancer agents. Here, we identified aminobenzothiazole derivatives as novel inhibitors of Aurora B kinase through bioisosteric replacement of the previous inhibitors, aminobenzoxazole derivatives. Most of the urea linked aminobenzothiazole derivatives showed potent and selective inhibitory activity against Aurora B kinase over Aurora A kinase. Molecular modeling indicated that compound 15g bound well to the active site of Aurora B kinase and formed the essential hydrogen bonds. The potent compounds, 15g and 15k, were selected, and their biological effects were evaluated using HeLa cell lines. It was found that these compounds inhibited the phosphorylation of histone H3 at Ser10 and induced G(2)/M cell cycle arrest. We suggest that the reported compounds have the potential to be further developed as anticancer therapeutics. (C) 2017 Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.bmc.2017.04.004 | - |
dc.identifier.scopusid | 2-s2.0-85019383272 | - |
dc.identifier.wosid | 000404087700004 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.25, no.14, pp 3614 - 3622 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 25 | - |
dc.citation.number | 14 | - |
dc.citation.startPage | 3614 | - |
dc.citation.endPage | 3622 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | MITOSIS | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | INCENP | - |
dc.subject.keywordAuthor | Aminobenzothiazole | - |
dc.subject.keywordAuthor | Aurora B kinase | - |
dc.subject.keywordAuthor | Antiproliferation | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/abs/pii/S0968089616315115?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.